Product NDC: | 36987-2587 |
Proprietary Name: | Salt Cedar |
Non Proprietary Name: | Salt Cedar |
Active Ingredient(s): | .05 g/mL & nbsp; Salt Cedar |
Administration Route(s): | INTRADERMAL; SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 36987-2587 |
Labeler Name: | Nelco Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA102192 |
Marketing Category: | BLA |
Start Marketing Date: | 19720829 |
Package NDC: | 36987-2587-2 |
Package Description: | 10 mL in 1 VIAL, MULTI-DOSE (36987-2587-2) |
NDC Code | 36987-2587-2 |
Proprietary Name | Salt Cedar |
Package Description | 10 mL in 1 VIAL, MULTI-DOSE (36987-2587-2) |
Product NDC | 36987-2587 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Salt Cedar |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRADERMAL; SUBCUTANEOUS |
Start Marketing Date | 19720829 |
Marketing Category Name | BLA |
Labeler Name | Nelco Laboratories, Inc. |
Substance Name | TAMARIX GALLICA POLLEN |
Strength Number | .05 |
Strength Unit | g/mL |
Pharmaceutical Classes | Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient] |